IPC is an autonomous institution of the MoHFW, GoI. IPC was created on 01/01/2009 and entrusted with the mandate to set standards for drugs in the country.
Ghaziabad, India
Joined March 2016
- Tweets16.9K
- Following42
- Followers3.3K
- Likes169
Indian Pharmacopoeia Commission (IPC) retweeted
Applications are invited for 39th Skill Development Programme on Pharmacovigilance scheduled from 16th-20th November 2026.
Mode: Online
Registration Fee: Rs. 2000/-
Last Date of Registration: 12th November 2026
Registration link: lnkd.in/gVi3MjRv
Indian Pharmacopoeia Commission (IPC) retweeted
Be a part of this prestigious gathering as we recognise excellence, celebrate impactful contributions, and work together towards strengthening the future of medicine quality in India.
Indian Pharmacopoeia Commission (IPC) retweeted
🔴 LIVE | 10:00 AM | Hon’ble MoS Health Smt. Anupriya Patel, to release the 7th Edition of National Formulary of India
📅 21 September 2026 | 10:00 AM
▶️ Watch LIVE here: youtube.com/live/-kHsW99txFY
Indian Pharmacopoeia Commission (IPC) retweeted
Indian Pharmacopoeia Commission (@ipcgzb) Inaugurates 6th National Pharmacovigilance Week with Focus on Rational Use of Medicines
6th National Pharmacovigilance Week to be Observed Across the Country from 17–23 September 2026
Week-Long Campaign to Sensitise Healthcare Professionals, Researchers and Public on Adverse Drug Reaction (ADR) Reporting and Encourage Active Participation in Pharmacovigilance
#HealthForAll
pib.gov.in/PressReleasePage.…
Indian Pharmacopoeia Commission (IPC) retweeted
Indian Pharmacopoeia Commission (@ipcgzb) Organizes National Conference on Quality and Safety of Biosimilars: Strengthening India’s Biopharma SHAKTI Vision
Conference Aligns with the Government’s #BiopharmaSHAKTI Vision to Strengthen India’s Biopharmaceutical Ecosystem through Innovation, Self-Reliance, Quality and Global Competitiveness
IPC Launches Indian Pharmacopoeia Reference Substance (IPRS) for Enoxaparin Sodium for bioassays
#HealthForAll
pib.gov.in/PressReleaseDetai…
Indian Pharmacopoeia Commission (IPC) retweeted
#HealthForAll
Indian Pharmacopoeia Commission (IPC) Organises First-Ever Interactive Meeting with CDL Kolkata to Promote Quality of Medicines
“IP 2026: Perspectives, Suggestions & Way Forward” Focuses on Strengthening Pharmacopoeial Standards and Drug Quality
IPC Launches Seven Indian Pharmacopoeia Nitrosamine Impurities Reference Standards for the First Time
Seven Nitrosamine Reference Standards to Strengthen Accurate Detection, Quality Assurance and Regulatory Compliance of Pharmaceuticals
pib.gov.in/PressReleasePage.…
Indian Pharmacopoeia Commission (IPC) retweeted
Join the Scientific Conclave & Interactive Session on #IndianPharmacopoeia2026 organised by @ipcgzb in collaboration with @GuwahatiNiper
Date: 27 Aug 2026
Venue: NIPER Guwahati
Register by scanning the QR code in the flyer.
Indian Pharmacopoeia Commission (IPC) retweeted
Shri Prataprao Jadhav, Hon’ble MoS (IC) for Ayush & MoS for Health & Family Welfare, graced the formal exchange of the MoU between PCIM&H, Ministry of Ayush and IPC, Ministry of Health & Family Welfare, under the “One Herb, One Standard” initiative at Kartavya Bhavan, New Delhi.
The MoU was exchanged by Dr. Kousthubha Upadhyaya, Director I/c, PCIM&H, and Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, in the presence of Vaidya Rajesh Kotecha, Secretary, Ministry of Ayush, and senior officials and scientists from both institutions.
Renewed for three years, the partnership will advance uniform, scientific and reliable standards for herbal medicines across Ayurveda, Siddha, Sowa-Rigpa, Unani and Homoeopathy.
#OneHerbOneStandard #MinistryOfAyush
@PMOIndia | @narendramodi | @mpprataprao | @secymoayush | @PIB_India | @PIBAYUSH | @DDNewslive | @sansad_tv | @AIRNewsHindi | @mygovindia | @MyGovHindi | @MoHFW_INDIA
Indian Pharmacopoeia Commission (IPC) retweeted
Join the Brainstorming Session on AI-Powered Pharmacopoeia Standards Development & Pharmacovigilance Practices hosted by the Indian Pharmacopoeia Commission.
📅20 Aug 2026
📷9:00 AM–4:30 PM
📷Fee: 1,180 (incl. GST)
Register:forms.gle/N4UTP7Zy3rrADhU99
Indian Pharmacopoeia Commission (IPC) retweeted
Indian Pharmacopoeia Commission (IPC) Recognized by WHO SEARN as Regional Centre of Excellence in Pharmacovigilance and Technical Centre in Quality of Medicines
⇒IPC Recognized for Strengthening Pharmacovigilance and Quality of Medicines Across the South-East Asia Region
⇒IPC Showcases India's Regulatory Excellence at WHO SEARN's 10th Anniversary Meeting in Nepal
Details here: pib.gov.in/PressReleasePage.…
@MoHFW_INDIA
Indian Pharmacopoeia Commission (IPC) retweeted
Prof. (Dr.) M. Srinivas, Member (Health), NITI Aayog, held discussions with Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission (IPC), to explore collaborative initiatives for strengthening pharmacovigilance, materiovigilance, and healthcare systems in India.
The discussions explored the establishment of Pharmacovigilance Programme of India (PvPI) and Materiovigilance Programme of India (MvPI) Centres in Aspirational Districts to strengthen patient safety and healthcare systems at the grassroots. Deliberations also covered aligning the standards of the Indian Pharmacopoeia with the Sustainable Development Goals (SDGs), promoting the National Formulary of India among registered medical practitioners through the National Medical Commission, and advancing collaboration to strengthen healthcare delivery.
Dr. Y. K. Gupta, President, AIIMS Kalyani; Dr. Pooja Gupta, Department of Pharmacology, AIIMS New Delhi; and Dr. T. Velpandian, Dr. R. P. Centre for Ophthalmic Sciences, AIIMS New Delhi, joined the discussions virtually.
Prof. (Dr.) M. Srinivas emphasised the importance of taking such initiatives across the medical and pharmaceutical ecosystem to the last mile in support of the vision of Viksit Bharat.
#Healthcare #PatientSafety
@PMOIndia @narendramodi @Rao_InderjitS @MIB_India @PIB_India @DDNewslive @ashoklahiribjp @ipcgzb
Indian Pharmacopoeia Commission (IPC) retweeted
#HealthForAll
Indian Pharmacopoeia Commission Represents India at the 16th International Meeting of World Pharmacopoeias in Brazil
Indian Pharmacopoeia Highlights Advancements in Pharmacopoeial Standards and Global Harmonization Efforts; Standards Reaffirmed as Comparable with Leading International Pharmacopoeias
India Recognized for Leadership in Developing Quality Standards for Anti-Tuberculosis, Anti-Cancer and Anaemia Medicines, Blood Products and Other Complex Pharmaceutical Products
Collaboration with International Pharmacopoeias Strengthened; India's Growing Leadership in Advancing Global Pharmaceutical Quality Standards Reaffirmed
pib.gov.in/PressReleasePage.…
Indian Pharmacopoeia Commission (IPC) retweeted
#HealthForAll
Scientific Conclave on Indian Pharmacopoeia (IP) 2026 Held in Haridwar; Highlights Role of Pharmacopoeial Standards in Strengthening Pharmaceutical Quality
IPC Strengthens Industry Preparedness for IP 2026 Through Awareness and Capacity-Building Initiatives
IP 2026 Conclave Encourages Wider Adoption of Pharmacopoeial Standards, Provides Handholding Support to Pharmaceutical Industry
IPC Advances Stakeholder Engagement to Foster Pharmaceutical Quality and Manufacture of Quality-Assured Medicines
pib.gov.in/PressReleasePage.…
Indian Pharmacopoeia Commission (IPC) retweeted
Applications are invited for 37th SDP on Pharmacovigilance scheduled from 15th-19th June 2026.
Registration Fee: INR 10,000/- (including GST)
Mode: Offline
Last Date of Application: 8th June 2026
Venue: NCC-PvPI, IPC, Ghaziabad, 201002
Organized By: NCC-PvPI, IPC, Ghaziabad.
Indian Pharmacopoeia Commission (IPC) retweeted
Workshop on “Enhancing Scientific Publications in Pharmacopoeial Science and Pharmacovigilance” scheduled from 09th-10th April, 2026.
Fees: INR 1180/- (including GST)
Mode: In- Person
Registration link: docs.google.com/forms/d/e/1F…
Last date to apply: 06.04.2026
Venue: IPC, Ghaziabad
Indian Pharmacopoeia Commission (IPC) retweeted
#HealthForAll
Indian Pharmacopoeia Commission (@ipcgzb) and Andhra Pradesh MedTech Zone (@AP_MedTechZone) Organise National Meet on Strengthening Pharmacovigilance and Materiovigilance in India at Visakhapatnam
First-Ever National Annual Meet of PvPI and MvPI Regional Centres to Strengthen India’s Drug and Medical Device Safety Framework and Institutional Coordination
ADR PvPI 2.0 Mobile Application Launched during the Meet to Enhance Real-Time Adverse Drug Reaction Reporting and Patient Safety Across India
From Awareness to Action: National Meet Drives Coordinated, Technology-Enabled Transformation of Drug and Medical Device Safety and Patient Protection in India
pib.gov.in/PressReleasePage.…
Indian Pharmacopoeia Commission (IPC) retweeted
#HealthForAll
Indian Pharmacopoeia Commission Signs Three MoUs to Bolster Medicine Safety, Quality Standards, and Capacity Building
@ipcgzb–Goa State Pharmacy Council (GSPC) MoU to Enhance Pharmacovigilance, Promote Rational Medicine Use, and Strengthen Pharmacist Training and Drug Safety Systems in Goa
IPC–@QualityCouncil MoU to Drive Healthcare Quality Promotion, Public Awareness, and Capacity Building through Joint Initiatives
pib.gov.in/PressReleasePage.…
Indian Pharmacopoeia Commission (IPC) retweeted
Today at the Indian Pharmacopoeia 2026 Release Ceremony, Union Health Minister Shri Jagat Prakash Nadda underscored India’s advancement in drug safety, with the global Pharmacovigilance ranking improving from 123rd to 8th.
#IndianPharmacopoeia #IP2026 #DrugSafety
Indian Pharmacopoeia Commission (IPC) retweeted
Released the 10th edition of the Indian Pharmacopoeia 2026 in New Delhi today. This updated edition strengthens India’s commitment to quality, safety, and efficacy of medicines through robust and science-based standards. It reflects global best practices and highlights India’s growing role in pharmaceutical manufacturing and regulation.
Indian Pharmacopoeia standards are now accepted internationally and recognised in 19 countries, emerging as an important pillar of India’s health diplomacy. These efforts align with the vision of Hon’ble Prime Minister Shri @narendramodi ji to build strong and resilient healthcare systems.
